Biofrontera Inc (NASDAQ:BFRI) currently has a daily average trading volume of 148.45K but it saw 802919 shares traded in last market. With a market cap of 7.31M USD, the company’s current market price of $1.32 came rising about 15.79 while comparing to the previous closing price of $1.14. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.52 and as low as $0.61. In the recent trading on the day, stock has struck highest price mark of $1.12 while lowest mark touched by it was $1.34.
Taking a look at 20-day trading activity of Biofrontera Inc (BFRI) gives us an average price of $1.1747, while its current price level is -86.13% below from 52-week high level whereas it is 116.39% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1161 while that of 200 days or SMA-200 reads an average of $1.5546. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.62% during that period while stretching the period over a month that increases to 11.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 60.32 which implies that the stock is in neutral territory.
Over the week, BFRI’s stock price is moving 15.79% up while it is 10.00% when we observe its performance for the past one month. Year-to-date it is -52.35% down and over the past year, the stock is showing a downside performance of -84.47%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -4.64 beaten by the consensus estimate of -3.78 for the same. The company is expected to be releasing its next quarterly report in October, for which analysts forecasted an EPS of -0.83 while estimate for next year EPS is -3.21. In next quarter, company is expected to be making quarterly sales of $14.05M as analysts are expecting the sales for current fiscal year at $39.79M and seeing the company making $47.81M in sales next year. Moreover, analysts are in estimates of $10.01M for current-quarter revenue.
Currently, Biofrontera Inc’s total number of outstanding shares is 5.54M. Company’s return on investment (ROI) stands at -118.99% and return on equity (ROE) at -149.41%. Stock’s beta reads 0.41. Stock has a price to book (P/B) ratio of 0.62 while price to sale or P/S ratio amounts to 0.21. Its return on asset (ROA) is -46.20% on average.
